Faculty Collaboration Database

Inpatient Financial Burden of Atopic Dermatitis in the United States. J Invest Dermatol 2017 Jul;137(7):1461-1467

Date

03/06/2017

Pubmed ID

28259687

DOI

10.1016/j.jid.2017.02.975

Scopus ID

2-s2.0-85021323335 (requires institutional sign-in at Scopus site)   50 Citations

Abstract

Little is known about the inpatient burden of atopic dermatitis (AD). We sought to determine the risk factors and financial burden of hospitalizations for AD in the United States. Data were analyzed from the 2002-2012 National Inpatient Sample, including a 20% representative sample of all hospitalizations in the United States. Hospitalization rates for AD or eczema were highest in the northeast during the winter and south during the summer. Geometric mean cost of care (95% confidence interval) was lower for a primary diagnosis of AD or eczema versus no AD or eczema in adults ($3,502 [$3,360-$3,651] vs. $6,849 [$6,775-$6,925]; P = 0.0004) and children ($2,716 [$2,542-$2,903] vs. $4,488 [$4,302-$4,682]; P = 0.0004). However, the high prevalence of hospitalization resulted in total inpatient costs of $8,288,083 per year for adults and $3,333,868 per year for children. In conclusion, there is a substantial inpatient financial burden of AD in the United States.

Author List

Narla S, Hsu DY, Thyssen JP, Silverberg JI

Author

Shanthi Narla MD Assistant Professor in the Dermatology department at Medical College of Wisconsin

MESH terms used to index this publication - Major topics in bold

Adolescent
Adult
Child
Cost of Illness
Costs and Cost Analysis
Dermatitis, Atopic
Female
Health Care Costs
Hospitalization
Humans
Inpatients
Male
Prevalence
Retrospective Studies
United States
Young Adult